The 4DMedical Ltd (ASX: 4DX) share price is in focus after the company posted a 21% lift in revenue to $7.1 million for FY26, with adjusted net loss improving 7% to $32.9 million.

What did 4DMedical report?

• Revenue from ordinary activities up 21% to $7.1 million
• Adjusted net loss down 7% to $32.9 million
• Statutory net loss expanded to $203 million (from $30.1 million a year ago), driven by significant non-cash items
• Gross margins remained above 90%
• No dividend declared or paid
• Net tangible assets per share improved to $0.17 (from negative $0.02)

What else do investors need to know?

4DMedical’s underlying SaaS revenue climbed 23%, supported by strong growth from B2B hospital and radiology partners, third-party AI distributors, and global medical technology companies. The loss at the statutory level included a major non-cash impact—remeasurement of the Pro Medicus loan and associated derivative financial instrument—reflecting complex accounting treatment rather than core business cash outflows.

The company raised $233 million through share placements and finished the year with a robust $278 million in cash, positioning it well for ongoing investment and expansion. No dividends were declared for FY26.

What did 4DMedical management say?

Dr. Andreas Fouras, Managing Director and CEO, commented:

4DMedical has maintained strong momentum throughout FY26, improving our adjusted net loss result and strengthening our balance sheet so we can accelerate future growth initiatives.

What’s next for 4DMedical?

Looking ahead, 4DMedical recently completed the acquisition of contextflow GmbH, an Austrian lung cancer screening technology company. The group also led a strategic investment in RevealDx, securing exclusive distribution rights for RevealAI-lung across key markets, including Europe, Australia, and New Zealand.

Management plans to continue scaling its commercial partnerships and integrating new technologies, while building a globally competitive medical imaging and AI platform.

4DMedical share price snapshot

Over the past 12 months, 4DMedical shares have risen nearly 700%, far outpacing the All Ordinaries Index (ASX: XAO).

View Original Announcement

The post 4DMedical share price rises as FY26 revenue climbs, losses moderate appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• 4DMedical shares are up 670% — but why have they halved?
• Are Pro Medicus shares now too cheap to ignore?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Flight Centre Travel Group Ltd (ASX: FLT), Air New Zealand Ltd (ASX: AIZ), and Virgin Australia Holdings Ltd (ASX: VGN) shares are turning heads on Friday.

In morning trade today, two of the well-known ASX shares are outpacing the 0.2% gains posted by the All Ordinaries Index (ASX: XAO), while one is trailing the benchmark.

Here’s what’s catching investor interest.

Virgin Australia shares rise on renewed dividend

Virgin Australia shares are up 1.1% at the time of writing, swapping hands for $2.84 apiece.

This follows the release of the ASX 300 airline’s full-year FY 2026 results.

Highlights included a 13.4% year-on-year increase in underlying earnings before interest and tax (EBIT) to $753 million.

And on the bottom line, Virgin Australia shares look to be getting support today from the airline’s 21.9% increase in underlying net profit after tax (NPAT) to $404 million.

The company also issued its first dividend since relisting on the ASX in June 2025. Management declared a fully-franked dividend of 7.6 cents per share.

Air New Zealand shares sink on net loss

Air New Zealand also released its FY 2026 results today.

But unlike Virgin Australia shares, Air New Zealand shares are down 0.8% following the release, trading for 32.3 cents each.

On the positive side of the ledger, the Kiwi airline reported a 3.9% year-on-year increase in revenue to NZ$7.0 billion.

However, operating cash flow of NZ$819 million was down 12.8% from FY 2025.

And the company posted a net loss after tax of NZ$242 million.

Much of the pressure has come from surging jet fuel costs amid the ongoing Middle East conflict.

Air New Zealand management noted, “The Middle East conflict increased fuel cost by an estimated $328 million compared to what we expected going into the second half, and by $205 million after hedging.”

Flight Centre shares lift amid board shakeup

Joining Air New Zealand and Virgin Australia shares in creating a buzz today, we find Flight Centre.

After reporting its FY 2026 results on Wednesday, today the ASX 200 travel stock announced some major leadership changes.

Flight Centre revealed that Gareth Turner will join the board as an independent non-executive director. Turner will succeed Rob Baker, a 13-year veteran of the company’s board.

Commenting on Turner’s appointment, Flight Centre chair Gary Smith said:

Gareth brings deep financial and commercial experience across the technology, telecommunications and travel and tourism sectors, along with a strong track record as a CFO.

The board looks forward to drawing on his expertise as our company continues to evolve and targets near-term and longer-term growth opportunities.

Flight Centre shares are up 0.6% at the time of writing, trading for $12.26 apiece.

The post Why is everyone talking about Flight Centre, Air New Zealand and Virgin Australia shares on Friday? appeared first on The Motley Fool Australia.

More reading

• Virgin Australia shareholders are getting a dividend. Here’s how much
• Buy, hold, sell: Domino’s, Flight Centre, and WiseTech shares
• Virgin Australia posts robust FY26 results and first dividend since re-listing
• Flight Centre shares are sinking 7% after its FY26 results. Here’s why
• Flight Centre Travel Group delivers record year despite Q4 challenges

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Virgin Australia Holdings Ltd (ASX: VGN) shares are in the green on Friday after the airline released its FY26 results.

At the time of writing, the Virgin share price is up 2.14% to $2.87.

There were plenty of numbers for investors to unpack, with earnings and revenue both moving higher during the year.

However, income investors may be paying particularly close attention to one part of the result.

Virgin Australia has declared its first dividend since returning to the ASX last year.

So, how much will shareholders receive?

Virgin Australia declares a fully-franked dividend

Virgin has declared a fully-franked dividend of 7.6 cents per share for FY26.

It’s a notable moment for shareholders, with this being the airline’s first dividend since returning to the ASX last year.

At the current share price of $2.87, the payment works out to a yield of almost 3% before franking credits.

The company said the dividend follows its capital allocation framework, which focuses on keeping the balance sheet strong and funding the business first.

Virgin Australia finished FY26 with net debt of $1.2 billion and leverage of 0.9 times underlying EBITDA, below its target range of 1 to 2 times.

It also had $1.84 billion in cash, cash equivalents, and term deposits at the end of June.

When will Virgin Australia pay its dividend?

Virgin shares are locked in to trade ex-dividend on 14 September.

The record date will follow on 15 September, with the dividend due to be paid one month later on 15 October.

And because it is fully franked, shareholders can also benefit from franking credits.

What did Virgin Australia report?

The airline delivered a stronger result in FY26, with underlying EBIT rising 13.4% to $753 million.

Underlying net profit after tax (NPAT) increased 21.9% to $404 million, while statutory NPAT rose 4.7% to $501 million.

Underlying revenue increased 8.1% to $6.28 billion, helped by strong customer demand and growth across both the airline and Velocity businesses.

Virgin Australia’s airline segment reported underlying EBIT of $616 million, up 15.2%, while Velocity EBIT increased 12.3% to $143 million.

Operating cash flow also came in at $1.3 billion for the year.

What’s next on the horizon?

Seeing dividends return is another positive for shareholders since Virgin Australia relisted.

Looking ahead, the company said demand and forward bookings remain strong, although first-half FY27 underlying EBIT is expected to be relatively flat.

Domestic capacity is expected to fall by around 3% during the half, while revenue per available seat kilometre is forecast to rise 6% to 8%.

If earnings keep moving in the right direction, shareholders could have more dividends to look forward to.

The post Virgin Australia shareholders are getting a dividend. Here’s how much appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about Flight Centre, Air New Zealand and Virgin Australia shares on Friday?
• Virgin Australia posts robust FY26 results and first dividend since re-listing
• 2 ASX travel stocks to buy and one to sell
• Buy, hold, sell: Orora, Virgin Australia, and ResMed shares
• 5 ASX shares I’d buy with $5,000 in August

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.